Can't find a thread for PTI and as I am a very keen investor in the company, I thought it appropriate to get things 'rolling'.

It is a small, relatively speaking, biotech, with extremely interesting products. It also has three of those products 'on the market'. Sole products at that, with no competition! One is 'CroFab' for rattlesnake bite, another is DigiFab for Digoxin overdose and the other ViperaTab for yes, viper bites. All bringing income into the group, ie, funding not needed!

But my main interest is in the Angiotensin vaccine for high blood pressure and the other, Voraxaze, a product acquired when they took over a company called Enact. This product has a very large market as it treats methotrexate toxicity in cancer patients receiving the drug called Methotrexate, which has nasty side effects, but if they can be alleviated then it is very potent! This is where Voraxase comes to the fore, it prevents to a great degree the side effects of Methotrexate and therefore patients can be given much higher dosage!

Oh I forgot their BSE testing product which is sold through a company called Enfer, I don't get too excited with this one, but it does make a profit!

The shares having been scaling a higher level recently, deservedly so in my opinion. Results are due soon. Keep an eye on it, it should eventually be very much worth it!

sinutab, you sure you got a gp friend?

Biopharmaceuticals group Protherics plc,has confirmed it expects its royalties to be boosted by BSE scare in U.S.
It licensed the technology to Enfer Scientific,who in turn agreed that US giant Abbot Laborories,can market and distribute worldwide.
Abbot have been given permission to test market in the states.
There are no rapid BSE tests commerecially avalible in the US.

Up 3.25p.looking good.

Up 4.50p.looking better.

Things definately looking good.Lets hope the research for the cancer and high blood pressure products go to plan, if this happens one of the major players in the market will probably start to hover around the company.The big companies now don't have as many products in the pipeline and may look to invest in smaller firms and then bid for them.
It would be interesting if Protherics falls into this catergory and unbeknow to us plans may be a foot!
The pluses definately overshadow any minuses.

aevansdj,i agree with you,would be nice,now up 4.75p.

Been on the Buisiness Week Site

I found an article on there about the B.S.E. case found in the U.S.
It said only 20,000 of the 35,000,000 animals slaughtered in 2003 were tested for B.S.E by the U.S.D.A.
Abbott Labs which market the test made by Enfer have sold 2,000,000 tests since 2001.They cost $10-$13 per animal.It could be a good money spinner, if the U.S.D.A decide sticter testing, like other countries in the World, such as the U.K. and Japan is required.
Hopefully Abbotts Labs will get the approval to market the product.Although there are other firms in the frame.

http://www.businessweek.com

digitallook is showing a buy of over 3 million this morning, yet the price has gone down??

anyone know anything?

The 3m buy is only a trade deal,so will not effect the share price.